Cite

HARVARD Citation

    Veccia, A. et al. (2016). Clinical outcomes in octogenarians treated with docetaxel as first-line chemotherapy for castration-resistant prostate cancer. Future oncology. pp. 493-502. [Online]. 
  
Back to record